GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Medipal Holdings Corp (TSE:7459) » Definitions » Retained Earnings

Medipal Holdings (TSE:7459) Retained Earnings : 円426,127 Mil (As of Dec. 2023)


View and export this data going back to 1995. Start your Free Trial

What is Medipal Holdings Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Medipal Holdings's retained earnings for the quarter that ended in Dec. 2023 was 円426,127 Mil.

Medipal Holdings's quarterly retained earnings increased from Jun. 2023 (円421,082 Mil) to Sep. 2023 (円426,877 Mil) but then declined from Sep. 2023 (円426,877 Mil) to Dec. 2023 (円426,127 Mil).

Medipal Holdings's annual retained earnings increased from Mar. 2021 (円365,291 Mil) to Mar. 2022 (円385,611 Mil) and increased from Mar. 2022 (円385,611 Mil) to Mar. 2023 (円414,723 Mil).


Medipal Holdings Retained Earnings Historical Data

The historical data trend for Medipal Holdings's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medipal Holdings Retained Earnings Chart

Medipal Holdings Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 321,242.00 350,562.00 365,291.00 385,611.00 414,723.00

Medipal Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 405,765.00 414,723.00 421,082.00 426,877.00 426,127.00

Medipal Holdings Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.


Medipal Holdings  (TSE:7459) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Medipal Holdings (TSE:7459) Business Description

Traded in Other Exchanges
Address
2-7-15, Yaesu, Chuo-ku, Tokyo, JPN, 104-8461
Medipal Holdings Corp distributes pharmaceuticals and health and beauty products to medical institutions and retailers. The firm operates in three segments: prescription pharmaceutical wholesale; cosmetics, daily necessities, and OTC pharmaceutical wholesale; and animal health products wholesale. The prescription pharmaceutical business generates the majority of revenue and distributes products to hospitals, clinics, and pharmacies. The cosmetics, daily necessities, and OTC pharmaceutical businesses distribute products to drugstores, convenience stores, and supermarkets. The animal health segment conducts wholesale business for animal hospitals, farms, and agricultural cooperatives. Medipal Holdings generates the vast majority of its revenue in Japan.

Medipal Holdings (TSE:7459) Headlines

No Headlines